Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Johnstown, PA MSA — September 2026
Johnstown's cheap labor can't substitute for scarce life sci talent.
Johnstown's unemployment rate fell to 4.4% even as nonfarm payrolls shrank 400 jobs year-over-year, underscoring why this low-wage metro (average weekly wages of $1,002 versus $1,654 nationally) remains a cost play, not a talent pipeline, for specialized life sciences roles.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Johnstown unemployment rate: 4.4% — Down from 4.7% in May; above PA's 4.1%
- Metro nonfarm payrolls: 49,800 — Down 400 jobs vs July 2025
- Average weekly wage, Johnstown: $1,002 — vs $1,654 US average (Q1 2026)
- CRA advertised pay, metro vs national: $80,883 — vs $90,956 national median, both rising
Key takeaways
Johnstown's wage gap is a cost lever, not a talent strategy.
Average weekly wages near $1,002 sit at roughly 60% of the national average, making the metro attractive for cost-sensitive back-office or support functions. It is not a viable location for competing on specialized regulatory, clinical, or CMC talent, where national scarcity drives pay well above what local wage data would suggest.
Falling unemployment here signals shrinking supply, not rising demand.
Unemployment dropped to 4.4% from 4.7% in May while total nonfarm jobs fell 400 year-over-year — a pattern consistent with workers exiting the labor force rather than employers expanding payrolls. Any staffing plan assuming elastic local labor supply for technical roles should be tested against this trend.
Statewide regulatory and CMC premiums make Philadelphia the real competitor.
VP Regulatory Affairs compensation nationally ranges $320K–$580K and Director CMC roles $220K–$520K, reflecting acute scarcity that no Johnstown-based hiring plan can realistically address. Leaders evaluating satellite site locations should benchmark against Philadelphia's talent density, not against this metro's cost structure.
CRA advertised pay is climbing faster locally than nationally.
Metro median advertised pay for Clinical Research Associates rose to $80,883, trailing the national $90,956 figure but moving up significantly in both geographies. Even in a low-wage metro, clinical research compensation is repricing upward — a signal that geographic arbitrage on this role class is narrowing faster than overall metro wage data implies.
Median advertised pay by role — Johnstown, PA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $89,211 | $124,624 | $141,205 | Significant increase | $131,354 |
| Clinical Research Associate * | $61,167 | $80,883 | $100,914 | Significant increase | $90,956 |
| Lab Technician * | $39,619 | $46,681 | $52,287 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $66,798 | $95,346 | $112,818 | Stable | $104,000 |
| Clinical Data Manager * | $97,693 | $142,800 | $164,232 | Moderate increase | $123,031 |
| Biostatistician * | $107,580 | $139,109 | $159,860 | Moderate increase | $133,322 |
| Validation Engineer * | $89,151 | $106,202 | $113,415 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Johnstown's unemployment rate eased to 4.4% in July, continuing a steady descent from 4.7% in May, even as nonfarm payrolls slipped 400 jobs year-over-year to 49,800 — a sign the metro's labor tightness reflects shrinking supply more than hiring strength. Average weekly wages of $1,002 remain barely 60% of the national $1,654 figure, a gap that keeps Johnstown a structurally low-cost option for any life sciences function that can be sited or sourced regionally rather than in Philadelphia or major biotech hubs.
What it means
Johnstown offers no meaningful bench of credentialed clinical, regulatory, or CMC talent, so any life sciences employer weighing a build-vs-outsource decision for specialized functions should treat this metro as a potential site for lower-complexity, lower-wage support roles — not a substitute for Philadelphia's regulatory and manufacturing density. The metro's falling unemployment alongside flat-to-shrinking payrolls suggests a shallow, not deepening, labor pool, raising the cost of any plan to scale clinical operations or quality functions locally. Consider evaluating Johnstown primarily for shared-services, data management, or administrative-adjacent life sciences roles where statewide wage compression works in the employer's favor, rather than for scarce scientific or regulatory talent.
Looking ahead
Worth watching: September-specific WARN notices and hiring announcements for the Johnstown MSA were not yet available at publication; confirm whether any statewide manufacturing or logistics layoffs (CJ Logistics, Kenco) draw displaced workers into adjacent counties.
Emerging pressure point: Pennsylvania's broader life sciences hiring surge — GSK recruiting 40+ roles and Insmed 60+ in Greater Philadelphia — continues to concentrate regulatory and manufacturing talent demand away from smaller metros, widening the competitive gap for any Johnstown-based site expansion.
Potential inflection point: Continued payroll contraction (-400 jobs year-over-year) alongside falling unemployment could flag labor force exit rather than tightening demand; a second consecutive month of this divergence would reinforce caution around local workforce scaling assumptions.
Early indicator: Statewide CDMO expansion (Minaris-Asimov AAV partnership) signals growing outsourcing capacity for cell and gene therapy manufacturing; watch whether similar capacity gets sited in lower-cost Western PA markets like Johnstown over the next two quarters.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.